Hemoptysis in Israeli CF patients - Prevalence, treatment, and clinical characteristics

Journal of Cystic Fibrosis

Volumn 7, Issue 4, 2008, Pages 301-306

  Efrati, Ori ^a   Harash, Oshrit ^a   Rivlin, Joseph ^b   Bibi, Haim ^b   Meir, Mei Zahav ^c   Blau, Hannah ^c   Mussaffi, Huda ^c   Barak, Asher ^a   Levy, Isaac ^a   Vilozni, Daphna ^a   Kerem, Eitan ^d   Modan Moses, Dalit ^a  

^a Safra Children's Hospital   (Israel)

^b CARMEL MEDICAL CENTER   (Israel)

^c SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^d HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Bronchial artery embolization; Cystic fibrosis; Hemoptysis; Portal hypertension; Pulmonary function tests; Survival

Indexed keywords

ANTIBIOTIC AGENT; TRANEXAMIC ACID; VITAMIN K GROUP;

ADOLESCENT; ADULT; ARTICLE; ARTIFICIAL EMBOLISM; BLOOD CLOTTING TEST; BODY MASS; BRONCHIAL ARTERY; BRONCHIECTASIS; CHILD; CLINICAL FEATURE; CONSERVATIVE TREATMENT; CONTROLLED STUDY; CYSTIC FIBROSIS; DEATH; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE EXACERBATION; FEMALE; FOLLOW UP; GENE MUTATION; HEMOPTYSIS; HUMAN; INCIDENCE; INTESTINE OBSTRUCTION; ISRAEL; LIVER CIRRHOSIS; LUNG FUNCTION TEST; LUNG INSUFFICIENCY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORTALITY; PANCREAS FUNCTION; PATIENT CARE; PORTAL HYPERTENSION; PREVALENCE; RECURRENT DISEASE; RISK FACTOR; SPUTUM CULTURE;

ADOLESCENT; ADULT; CHILD; CYSTIC FIBROSIS; FEMALE; HEMOPTYSIS; HUMANS; HYPERTENSION, PORTAL; ISRAEL; MALE; PREVALENCE; REGISTRIES; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 46749107210     PISSN: 15691993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcf.2007.11.007     Document Type: Article

References (29)

1. Cystic Fibrosis Foundation. Patient Registry 2005 Annual Data Report. Bethesda, MD : Cystic Fibrosis Foundation (2006)
2. In: Baltimore M.D. (Ed). Stedman's Medical Dictionary. 25th ed. Williams & Wilkins (1990) 701
3. Firth J. Pulmonary hemorrhage and massive hemoptysis. In: Chernick V., and Kendig Jr. E.L. (Eds). Kendig's Disorders of the Respiratory Tract in Children. 5th ed. (1990), WB Saunders Company 966-976 Philadelphia, PA
4. Di Sant'Agnese P., and Davis P. Cystic fibrosis in adults. Am J Med 66 (1979) 121-132
5. Porter D., Van Every M., Anthracite R., and Mack Jr. J. Massive hemoptysis in cystic fibrosis. Arch Intern Med 143 (1983) 287-290
6. Vidal V., Therasse E., Berthiaume Y., Bommart S., Giroux M., Oliva V., et al. Bronchial artery embolization in adults with cystic fibrosis: impact on the clinical course and survival. J Vasc Interv Radiol 17 (2006) 953-958
7. Schidlow D., Taussig L., and Knowles M. Cystic Fibrosis Foundation Consensus. Conference report on pulmonary complications of cystic fibrosis. Pediatr Pulmonol 15 (1993) 187-198
8. Mack J., Moss A., and Harper W. The bronchial arteries in cystic fibrosis. Br J Radiol 38 (1965) 422-429
9. Moss A., Desilets D., Higashino S., Ruttenberg H., Marcano B., and Dooley R. Intrapulmonary shunts in cystic fibrosis. Pediatrics 41 (1968) 438-445
10. Brinson G., Noone P., Mauro M., Knowles M., Yankaskas J., Sandhu J., et al. Bronchial artery embolization for the treatment of hemoptysis in patients with cystic fibrosis. Am J Respir Crit Care Med 157 (1998) 1951-1958
11. Rabin H., Butler S., Wohl M., Geller D., Colin A., Schidlow D., et al. Pulmonary exacerbations in cystic fibrosis. Pediatr Pulmonol 37 (2004) 400-406
12. American Thoracic Society. Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis 144 (1991) 1202-1218
13. Sweezey N., and Fellows K. Bronchial artery embolization for severe hemoptysis in cystic fibrosis. Chest 97 (1990) 1322-1326
14. Flume P., Yankaskas J., Ebeling M., Hulsey T., and Clark L. Massive hemoptysis in cystic fibrosis. Chest 128 (2005) 729-738
15. Barben J., Ditchfield M., Carlin J., Robertson C., Robinson P., and Olinsky A. Major haemoptysis in children with cystic fibrosis: a 20-year retrospective study. J Cyst Fibros. 2 (2003) 105-111
16. FitzSimmons S. The changing epidemiology of cystic fibrosis. J Pediatr 122 (1993) 1-9
17. Coss Bu J., Sachdeva R., Bricker J., Harrison G., and Jefferson L. Hemoptysis: a 10-year retrospective study. Pediatrics 100 (1997) E7
18. McDonald D. Angiogenesis and remodeling of airway vasculature in chronic inflammation. Am J Respir Crit Care Med 164 (2001) S39-S45
19. McColley S., Stellmach V., Boas S., Jain M., and Crawford S. Serum vascular endothelial growth factor is elevated in cystic fibrosis and decreases with treatment of acute pulmonary exacerbation. Am J Respir Crit Care Med 161 (2000) 1877-1880
20. Stern R., Wood R., Boat T., Matthews L., Tucker A., and Doershuk C. Treatment and prognosis of massive hemoptysis in cystic fibrosis. Am Rev Respir Dis 117 (1978) 825-828
21. Antonelli M., Midulla F., Tancredi G., Salvatori F., Bonci E., Cimino G., et al. Bronchial artery embolization for the management of nonmassive hemoptysis in cystic fibrosis. Chest 121 (2002) 796-801
22. Fellows K., Stigol L., Shuster S., Khaw K., and Shwachman H. Bronchial artery embolization in cystic fibrosis: technique and long-term results. J Pediatr 95 (1979) 959-963
23. Ivanick M., Thorwarth W., Donohue J., Mandell V., Delany D., and Jaques P. Infarction of the left main stem bronchus: a complication of bronchial artery embolization. Am J Roentgenol 141 (1983) 535-537
24. Helenon C., Chatel A., Bigot J., and Brocard H. Left esophagobronchial fistula following bronchial artery embolization. Nouv Presse Med 6 (1977) 4209
25. Dichiro G. Unintentional spinal cord arteriography: a warning. Radiology 112 (1974) 231-233
26. Lemoigne F., Rampal P., and Petersen R. Fatal ischemic colitis after bronchial artery embolization. Nouv Presse Med 12 (1983) 2056-2057
27. Fraser K., Grosman H., Hyland R., and Tullis D. Transverse myelitis: a reversible complication of bronchial artery embolization in cystic fibrosis. Thorax 52 (1997) 99-101
28. Olivier K., Weber D., Wallace Jr. R., Faiz A., Lee J., Zhang Y., et al. Nontuberculous Mycobacteria in Cystic Fibrosis Study Group. Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis. Am J Respir Crit Care Med 167 (2003) 828-834
29. Derelle J., Bertolo-Houriez E., Marchal F., Weber M., Virion J., and Vidailhet M. Respiratory evolution of patient with mucoviscidosis treated with mucolytic agents plus dornase alfa. Arch Pediatr 5 (1998) 371-377